We then evaluated PDEi modulation of cAMP/PKA and cGMP/PKG signaling in NSCLC by measuring the phosphorylation of the downstream target vasodilator-stimulated protein (VASP, Figure 2C and Figure S2). The gene discussed is PRKG1; the disease is non-small cell lung carcinoma.